JTR  Vol.5 No.1 , March 2017
TNF-α (Tumor Necrosis Factor Alpha) and iNOS (Inducible Nitric Oxide Synthase) Expression in Rat Brain Infected by Mycobacterium tuberculosis Strain H37RV
Abstract: Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis. Mycobacterium tuberculosis will form the primary focus or Ghon focus in the lungs of infected people. The primary focus can break and get into the bloodstream and/or lymph to the entire body, including the central nervous system, especially the brain. Tuberculosis infection in the brain can cause microglia secrete inflammatory factors such as TNF-α and IL-1β is emerging as the body’s immune response. The factors that can trigger microglia to secrete iNOS (Inducible Nitric Oxide Synthase) in order to protect the brain from attacking bacteria. iNOS is shown to have an important role in tuberculosis infection in the brain. TNF-α is a pro-inflammatory cytokine which is mostly produced by macrophages/microglia through several mechanisms. Therefore, to investigate how the expression of TNF-α and iNOS in the brain tissue of the mice is not infected with tuberculosis, tuberculosis infection with an incubation period of 8 weeks and 16 weeks. This study is a semiquantitative study by comparing the amount of expression of TNF-α and iNOS and all three groups of samples with treatment as has been mentioned. The expressions observation of TNF-α and iNOS in brain cell tissue of mice was conducted using immunohistochemical staining, and was seen in a microscope with a magnification of ×100. Brain cells that express TNF-α and iNOS are brown core, cytoplasm and cell walls. The results were obtained by the longer exposure to infection of the higher expression of TNF-α (r > 0688) and the expression of iNOS decreased (0.993).
Cite this paper: Hidayati, D. , Sujuti, H. , Wulandari, L. , Saputra, A. and Santoso, G. (2017) TNF-α (Tumor Necrosis Factor Alpha) and iNOS (Inducible Nitric Oxide Synthase) Expression in Rat Brain Infected by Mycobacterium tuberculosis Strain H37RV. Journal of Tuberculosis Research, 5, 58-68. doi: 10.4236/jtr.2017.51006.

[1]   WHO (2013) Global Tuberculosis Report.

[2]   Rock, R.B., Olin, M., Baker, C.A., Molitor, T.W. and Peterson, P.K. (2008) Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects. Clinical Microbiology Reviews, 21, 243-361.

[3]   Lawn, S.D., Wood, R. and Wilkinson, R.J. (2011) Changing Concepts of “Latent Tuberculosis Infection” in Patients Living with HIV Infection. Clinical and Developmental Immunology, 2011, Article ID: 980594.

[4]   Walgreen, M., Calvete, D. and de Swart, H.E. (2002) Growth of Large-Scale Bed Forms Due to Storm-Driven and Tidalcurrents: A Model Approach. Continental Shelf Research, 22, 2777-2793.

[5]   Coppack, S.W. (2001) Pro-Inflammatory Cytokines and Adipose Tissue. Proceedings of Nutrition Society, 60, 349-356.

[6]   Skoog, T., Dichtl, W., Boquist, S., Andersson, S., Karpe, F., Tang, R., Bond, M.G., Faire, U., Nilsson, J., Eriksson, P. and dan Hamsten, A. (2002) Plasma Tumour Necrosis Factor and Early Carotid Atherosclerosis in Healthy Middle Aged Men. European Heart Journal, 23, 376-383.

[7]   Sukhanov, S., Higashi, Y., Yung Shai, S., Vaughn, C., Mohler, J., Li, Y., Song, H. and Titterington, Y.P. (2007) IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atheroschlerosis Progresion in ApoE-Deficient Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 2684-2690.

[8]   Petruson, K., Stalfors, J., Jacobsson, K.E., Ny, L. and Petruson, B. (2005) Nitric Oxide Production in the Sphenoidal Sinus by the Inducible and Constitutive Isozymes of Nitric Oxide Synthase. Rhinology, 43, 18-23.

[9]   Mungrue, I.N., Husain, M. and Stewart, D.J. (2002) The Role of NOS in Heart Failure: Lessons from Murine Genetic Models. Heart Failure Review, 7, 407-422.

[10]   Andrew, P.J. and Mayer, B. (1999) Enzymatic Function of Nitric Oxide Synthases. Cardiovascular Research, 43, 521-531.

[11]   Stuehr, D.J. (1999) Mammalian Nitric Oxide Synthases. Biochimica et Biophysica Acta, 1411, 217-230.

[12]   Tsenova, L., Bergtold, A., Freedman, V.H., Young, R.A. and Kaplan, G. (2000) Tumor Necrosis Factor α Is a Determinant of Pathogenesis and Disease Progression in Mycobacterial Infection in the Central Nervous System. Proceedings of the National Academy of Sciences, 96, 5657-5662.

[13]   Gary, D.S., Bruce-Keller, A.J., Kindy, M.S. and Mattson, M.P. (2000) Ischemic and Excitotoxic Brain Injury Is Enhanced in Mice Lacking the p55 Tumor Necrosis Factor Receptor. Journal of Cerebral Blood Flow & Metabolism, 18, 1283-1287.

[14]   Saldeen, J. and Welsh, N. (2004) p38 MAPK Inhibits JNK2 and Mediates Cytokine-Activated iNOS Induction and Apoptosis Independently of NF-KB Translocation in Insulin-Producing Cells. Eur Cytokine Netw. European Cytokine Network, 15, 47-52.

[15]   Jang, B.C., Paik, J.H., Kim, S.P., Bae, J.H., Mun, K.C., Song, D.K., Cho, C.H., Shin, D.H., Kwon, T.K., Park, J.W., Park, J.G., Baek, W.K., Suh, M.H., Lee, S.H., Baek, S.H., Lee, I.S. and Suh, S.I. (2004) Catalase Induces the Expression of Inducible Nitric Oxide Synthase through Activation of NF-kappaB and PI3K Signaling Pathway in Raw 264.7 Cells. Biochemical Pharmacology, 68, 2167-2176.

[16]   Miller, B.H., Fratti, R.A., Poschet, J.F., Timmins, G.S., Master, S.S., Burgos, M., Marletta, M.A. and Deretic, V. (2004) Mycobacteria Inhibit Nitric Oxide Synthase Recruitment to Phagosomes during Macrophage Infection. Infection and Immunity, 72, 2872-2878.